142 related articles for article (PubMed ID: 32588322)
1. Effects of HIV on the Tumor Microenvironment.
Dandachi D; Morón F
Adv Exp Med Biol; 2020; 1263():45-54. PubMed ID: 32588322
[TBL] [Abstract][Full Text] [Related]
2. Microenvironmental abnormalities induced by viral cooperation: Impact on lymphomagenesis.
De Paoli P; Carbone A
Semin Cancer Biol; 2015 Oct; 34():70-80. PubMed ID: 25837157
[TBL] [Abstract][Full Text] [Related]
3. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator.
Bais C; Santomasso B; Coso O; Arvanitakis L; Raaka EG; Gutkind JS; Asch AS; Cesarman E; Gershengorn MC; Mesri EA
Nature; 1998 Jan; 391(6662):86-9. PubMed ID: 9422510
[TBL] [Abstract][Full Text] [Related]
4. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment.
Dzobo K
OMICS; 2021 Jun; 25(6):358-371. PubMed ID: 34037476
[TBL] [Abstract][Full Text] [Related]
5. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
[TBL] [Abstract][Full Text] [Related]
6. HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies.
da Silva SR; de Oliveira DE
Cancer Lett; 2011 Jun; 305(2):175-85. PubMed ID: 21402436
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta.
Varthakavi V; Smith RM; Deng H; Sun R; Spearman P
Virology; 2002 Jun; 297(2):270-80. PubMed ID: 12083825
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
10. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
Katano H
Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
[TBL] [Abstract][Full Text] [Related]
11. Targeted inhibition of angiogenic factors in AIDS-related disorders.
Aoki Y; Tosato G
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):115-28. PubMed ID: 12769789
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
[TBL] [Abstract][Full Text] [Related]
13. The role of the tumor microenvironment in HIV-associated lymphomas.
Taylor JG; Liapis K; Gribben JG
Biomark Med; 2015; 9(5):473-82. PubMed ID: 25985176
[TBL] [Abstract][Full Text] [Related]
14. Human retroviruses: their role in cancer.
Blattner WA
Proc Assoc Am Physicians; 1999; 111(6):563-72. PubMed ID: 10591085
[TBL] [Abstract][Full Text] [Related]
15. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
16. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction targets in Kaposi's sarcoma.
Sullivan R; Dezube BJ; Koon HB
Curr Opin Oncol; 2006 Sep; 18(5):456-62. PubMed ID: 16894293
[TBL] [Abstract][Full Text] [Related]
18. Does dysregulated expression of a deregulated viral GPCR trigger Kaposi's sarcomagenesis?
Sodhi A; Montaner S; Gutkind JS
FASEB J; 2004 Mar; 18(3):422-7. PubMed ID: 15003988
[TBL] [Abstract][Full Text] [Related]
19. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene.
Jham BC; Montaner S
J Cell Biochem; 2010 May; 110(1):1-9. PubMed ID: 20213674
[TBL] [Abstract][Full Text] [Related]
20. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]